TELA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TELA Bio Inc is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently trading at a very low price with no significant positive catalysts or strong technical signals to suggest immediate upside potential. The company's financial performance shows revenue growth, but declining net income and EPS, along with a bearish technical trend, make this a high-risk investment. It is better to hold off for now.
The technical indicators for TELA are bearish. The MACD is negative and contracting, RSI is neutral at 20.771, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.71 and resistance at 1.095. There are no clear signals for a reversal or upward momentum.
Analysts maintain a Buy rating despite lowering the price target, citing confidence in the commercial strategy and recent key hires.
Technical indicators are bearish, and there is no recent news or significant trading activity from insiders, hedge funds, or Congress.
In Q3 2025, revenue increased by 9.14% YoY to $20,689,000. However, net income dropped by -17.06% YoY to -$8,603,000, and EPS declined by -54.76% YoY to -0.19. Gross margin slightly decreased to 67.52%. Overall, the financials indicate growth in revenue but worsening profitability metrics.
Canaccord lowered the price target from $7 to $4 but maintained a Buy rating. Analysts expressed confidence in the company's commercial strategy and recent hires despite a challenging Q3 and lowered full-year guidance.
